{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T23:53:37Z","timestamp":1726444417432},"reference-count":62,"publisher":"Walter de Gruyter GmbH","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec id=\"j_jpem-2018-0285_s_999\">\n<jats:title id=\"d2783957e3508\">Background<\/jats:title>\n<jats:p>Steroid 21-hydroxylase deficiency is an autosomal recessive disorder, present in 90\u201395% of all cases with congenital adrenal hyperplasia (CAH). The classical simple virilizing (SV) form of the disease causes virilization of the external genitalia in newborn females and pseudo-precocious puberty in both sexes, due to reactive androgen overproduction.<\/jats:p><\/jats:sec>\n<jats:sec id=\"j_jpem-2018-0285_s_998\">\n<jats:title id=\"d2783957e3516\">Case presentation<\/jats:title>\n<jats:p>We describe a 3.5-year-old girl presenting with pubarche, P2 according to Tanner, advanced bone age of 6 years and 10 months, and high serum levels of 17-hydroxyprogesterone (17-OHP). Molecular analysis of the nine most common pseudogene-derived <jats:italic>CYP21A2<\/jats:italic> point mutations was performed in the patient and her family members using the polymerase chain reaction\/amplification-created restriction site (PCR\/ACRS) method. We detected the P30L\/I172N genotype in the patient. She had inherited a mild P30L mutation from her mother and a severe I172N mutation from her father.<\/jats:p><\/jats:sec>\n<jats:sec id=\"j_jpem-2018-0285_s_997\">\n<jats:title id=\"d2783957e3527\">Conclusions<\/jats:title>\n<jats:p>Although the CAH phenotype is determined by the allele that produces most of the enzyme activity and the mild non-classical (NC) phenotype should be expected, the mild P30L known to be more virilizing probably induced the classical SV phenotype in our patient. A continuous regimen of hydrocortisone at a recommended dose failed to decrease the 17-OHP sufficiently. Careful tapering of the dose did not help, and her pubic hair advanced to P3 according to Tanner. Individually tailored treatment is warranted in this patient.<\/jats:p><\/jats:sec>","DOI":"10.1515\/jpem-2018-0285","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T09:04:42Z","timestamp":1556269482000},"page":"543-547","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic challenges in a patient with the simple virilizing (SV) form of congenital adrenal hyperplasia (CAH) due to the P30L\/I172N genotype"],"prefix":"10.1515","volume":"32","author":[{"given":"Maja","family":"Tankoska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violeta","family":"Anastasovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Krstevska-Konstantinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Naydenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"Kocova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref191","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1172\/JCI115897","article-title":"Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"90","year":"1992","journal-title":"J Clin Invest"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1530\/EC-18-0097","article-title":"Testicular adrenal rest tumors in boys with 21-hydroxylase deficiency, timely diagnosis and follow-up","volume":"7","year":"2018","journal-title":"Endocr Connect"},{"key":"ref11","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","year":"2000","journal-title":"Endocr Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1210\/jcem.86.1.7131","article-title":"Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"volume-title":"Growth at adolescence; with a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity","year":"1962","key":"ref71"},{"key":"ref101","first-page":"921","article-title":"Genotype-phenotype correlation in CAH patients with severe CYP21A2 point mutations in the Republic of Macedonia","volume":"23","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref201","first-page":"CD012517","article-title":"Glucocorticoid replacement regimens in the treatment of 21-hydroxylase deficiency congenital adrenal hyperplasia","volume":"1","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1074\/jbc.271.6.3306","article-title":"The common I172N mutation causes conformational change of cytochrome P450c21 revealed by systematic mutation, kinetic, and structural studies","volume":"271","year":"1996","journal-title":"J Biol Chem"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/jc.2013-1440","article-title":"Approach to the patient: the adult with congenital adrenal hyperplasia","volume":"98","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/mend-5-5-685","article-title":"A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele","volume":"5","year":"1991","journal-title":"Mol Endocrinol"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.beem.2008.09.010","article-title":"Novel strategies for hydrocortisone replacement","volume":"23","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-57-2-320","article-title":"Genotyping steroid 21-hydroxylase deficiency: hormonal reference data","volume":"57","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1073\/pnas.85.5.1600","article-title":"Mutation in the CYP21B gene (Ile172Asn) causes steroid 21-hydroxylase deficiency","volume":"85","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1210\/jc.2006-1645","article-title":"Extensive clinical experience: nonclassical 21-hydroxylase deficiency","volume":"91","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1210\/jcem.86.12.8090","article-title":"High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1056\/NEJM198807073190104","article-title":"Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"95","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/jc.2013-1440","article-title":"Approach to the patient: the adult with congenital adrenal hyperplasia","volume":"98","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2002-020611","article-title":"Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology","volume":"87","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2013.239","article-title":"Treatment and health outcomes in adults with congenital adrenal hyperplasia","volume":"10","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref61","first-page":"650","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"37","year":"1985","journal-title":"Am J Hum Genet"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.ge.23.120189.002103","article-title":"The molecular genetics of 21-hydroxylase deficiency","volume":"23","year":"1989","journal-title":"Annu Rev Genet"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/mend-5-5-685","article-title":"A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele","volume":"5","year":"1991","journal-title":"Mol Endocrinol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1210\/jcem.86.12.8090","article-title":"High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2013.239","article-title":"Treatment and health outcomes in adults with congenital adrenal hyperplasia","volume":"10","year":"2014","journal-title":"Nat Rev Endocrinol"},{"volume-title":"Growth at adolescence; with a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity","year":"1962","key":"ref381"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/jc.2008-1582","article-title":"Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1210\/jc.2006-1645","article-title":"Extensive clinical experience: nonclassical 21-hydroxylase deficiency","volume":"91","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1210\/jcem.86.1.7131","article-title":"Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1297\/cpe.24.77","article-title":"Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)","volume":"24","year":"2015","journal-title":"Clin Pediatr Endocrinol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-57-2-320","article-title":"Genotyping steroid 21-hydroxylase deficiency: hormonal reference data","volume":"57","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1297\/cpe.24.77","article-title":"Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)","volume":"24","year":"2015","journal-title":"Clin Pediatr Endocrinol"},{"key":"ref121","first-page":"53","article-title":"Direct molecular diagnosis of CYP21A2 point mutations in Macedonian and Serbian patients with 21-hydroxylase deficiency","volume":"34","year":"2015","journal-title":"J Med Biochem"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1172\/JCI115897","article-title":"Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"90","year":"1992","journal-title":"J Clin Invest"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000327794","article-title":"Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"76","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"ref321","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","year":"2000","journal-title":"Endocr Rev"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"110","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/adc.41.220.613","article-title":"Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II","volume":"41","year":"1966","journal-title":"Arch Dis Child"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jmg.33.5.371","article-title":"Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia","volume":"33","year":"1996","journal-title":"J Med Genet"},{"key":"ref131","first-page":"23","article-title":"Molecular analysis of a family with congenital adrenal hyperplasia - genotype\/phenotype discrepancy","volume":"10","year":"2007","journal-title":"BJMG"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"95","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref441","first-page":"23","article-title":"Molecular analysis of a family with congenital adrenal hyperplasia - genotype\/phenotype discrepancy","volume":"10","year":"2007","journal-title":"BJMG"},{"key":"ref371","first-page":"650","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"37","year":"1985","journal-title":"Am J Hum Genet"},{"key":"ref411","first-page":"921","article-title":"Genotype-phenotype correlation in CAH patients with severe CYP21A2 point mutations in the Republic of Macedonia","volume":"23","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jmg.33.5.371","article-title":"Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia","volume":"33","year":"1996","journal-title":"J Med Genet"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/jc.2008-1582","article-title":"Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.ge.23.120189.002103","article-title":"The molecular genetics of 21-hydroxylase deficiency","volume":"23","year":"1989","journal-title":"Annu Rev Genet"},{"key":"ref431","first-page":"53","article-title":"Direct molecular diagnosis of CYP21A2 point mutations in Macedonian and Serbian patients with 21-hydroxylase deficiency","volume":"34","year":"2015","journal-title":"J Med Biochem"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"624823","DOI":"10.1186\/1687-9856-2009-624823","article-title":"Testicular adrenal rest tumours in congenital adrenal hyperplasia","volume":"2009","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.beem.2008.09.010","article-title":"Novel strategies for hydrocortisone replacement","volume":"23","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref511","first-page":"CD012517","article-title":"Glucocorticoid replacement regimens in the treatment of 21-hydroxylase deficiency congenital adrenal hyperplasia","volume":"1","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/adc.41.220.613","article-title":"Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II","volume":"41","year":"1966","journal-title":"Arch Dis Child"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2002-020611","article-title":"Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology","volume":"87","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1530\/EC-18-0097","article-title":"Testicular adrenal rest tumors in boys with 21-hydroxylase deficiency, timely diagnosis and follow-up","volume":"7","year":"2018","journal-title":"Endocr Connect"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"624823","DOI":"10.1186\/1687-9856-2009-624823","article-title":"Testicular adrenal rest tumours in congenital adrenal hyperplasia","volume":"2009","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1074\/jbc.271.6.3306","article-title":"The common I172N mutation causes conformational change of cytochrome P450c21 revealed by systematic mutation, kinetic, and structural studies","volume":"271","year":"1996","journal-title":"J Biol Chem"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1056\/NEJM198807073190104","article-title":"Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000327794","article-title":"Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"76","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"110","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1073\/pnas.85.5.1600","article-title":"Mutation in the CYP21B gene (Ile172Asn) causes steroid 21-hydroxylase deficiency","volume":"85","year":"1988","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jpem.2019.32.issue-5\/jpem-2018-0285\/jpem-2018-0285.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2018-0285\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T01:44:27Z","timestamp":1619055867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2018-0285\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,27]]},"references-count":62,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1515\/jpem-2018-0285","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"type":"electronic","value":"2191-0251"},{"type":"print","value":"0334-018X"}],"subject":[],"published":{"date-parts":[[2019,5,27]]}}}